[go: up one dir, main page]

NO20082439L - Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma - Google Patents

Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma

Info

Publication number
NO20082439L
NO20082439L NO20082439A NO20082439A NO20082439L NO 20082439 L NO20082439 L NO 20082439L NO 20082439 A NO20082439 A NO 20082439A NO 20082439 A NO20082439 A NO 20082439A NO 20082439 L NO20082439 L NO 20082439L
Authority
NO
Norway
Prior art keywords
treatment
tiotropium salts
persistent asthma
moderate persistent
moderate
Prior art date
Application number
NO20082439A
Other languages
English (en)
Inventor
Michael Engel
Stefan Heinrichs
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35695896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20082439(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20082439L publication Critical patent/NO20082439L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Foreliggende oppfinnelse angår anvendelse av tiotropiumsalter for fremstilling av et medikament for behandling av pasienter som lider av moderat vedvarende astma.
NO20082439A 2006-01-04 2008-05-28 Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma NO20082439L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100055 2006-01-04
PCT/EP2006/070135 WO2007077162A1 (en) 2006-01-04 2006-12-22 Use of tiotropium salts in the treatment of moderate persistent asthma

Publications (1)

Publication Number Publication Date
NO20082439L true NO20082439L (no) 2008-08-04

Family

ID=35695896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082439A NO20082439L (no) 2006-01-04 2008-05-28 Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma

Country Status (30)

Country Link
US (2) US20070155773A1 (no)
EP (1) EP1971332B1 (no)
JP (1) JP2009525950A (no)
KR (1) KR20080083060A (no)
CN (1) CN101355937A (no)
AR (1) AR059126A1 (no)
AT (1) ATE500825T1 (no)
AU (1) AU2006334367B2 (no)
BR (1) BRPI0620886A2 (no)
CA (1) CA2634984C (no)
CY (1) CY1111534T1 (no)
DE (1) DE602006020620D1 (no)
DK (1) DK1971332T3 (no)
EA (1) EA015353B1 (no)
EC (1) ECSP088588A (no)
ES (1) ES2362306T3 (no)
HR (1) HRP20110200T1 (no)
IL (1) IL192602A (no)
ME (1) ME01205B (no)
MY (1) MY146362A (no)
NO (1) NO20082439L (no)
NZ (1) NZ570162A (no)
PL (1) PL1971332T3 (no)
PT (1) PT1971332E (no)
RS (1) RS51703B (no)
SI (1) SI1971332T1 (no)
TW (1) TW200731976A (no)
UA (1) UA95271C2 (no)
WO (1) WO2007077162A1 (no)
ZA (1) ZA200804436B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009504604A (ja) 2005-08-06 2009-02-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 重症持続型喘息の治療におけるチオトロピウム塩の使用
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN110876721A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 一种含有表面活性剂的噻托溴铵喷雾剂
CN110876720A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2425539A (en) * 1942-10-31 1947-08-12 Aro Equipment Corp Coupling
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
EP1326862B1 (de) * 2000-10-12 2004-09-15 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Kristallines monohydrat von tiotropiumbromid, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
ES2338563T3 (es) * 2003-11-03 2010-05-10 Boehringer Ingelheim International Gmbh Nuevo anhidrato cristalino con efecto anticolinergico.
PL2067779T3 (pl) * 2003-11-03 2013-09-30 Boehringer Ingelheim Int Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
KR20080011289A (ko) * 2005-05-10 2008-02-01 시너젠즈 바이오사이언스 리미티드 폐기능 및 폐질환을 평가하기 위한 성분 및 평가 방법
EP1888779A4 (en) * 2005-05-20 2009-06-10 Synergenz Bioscience Ltd METHOD FOR THE ANALYSIS OF POLYMORPHISMS AND USES THEREOF
JP2009504604A (ja) * 2005-08-06 2009-02-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 重症持続型喘息の治療におけるチオトロピウム塩の使用
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide

Also Published As

Publication number Publication date
DE602006020620D1 (de) 2011-04-21
EA015353B1 (ru) 2011-06-30
CY1111534T1 (el) 2015-08-05
EP1971332A1 (en) 2008-09-24
EA200801629A1 (ru) 2008-12-30
SI1971332T1 (sl) 2011-05-31
ECSP088588A (es) 2008-07-30
BRPI0620886A2 (pt) 2011-11-29
TW200731976A (en) 2007-09-01
JP2009525950A (ja) 2009-07-16
IL192602A0 (en) 2009-09-22
UA95271C2 (ru) 2011-07-25
AU2006334367A1 (en) 2007-07-12
DK1971332T3 (da) 2011-04-18
AR059126A1 (es) 2008-03-12
ZA200804436B (en) 2008-12-31
NZ570162A (en) 2011-09-30
ATE500825T1 (de) 2011-03-15
EP1971332B1 (en) 2011-03-09
CA2634984A1 (en) 2007-07-12
CA2634984C (en) 2014-05-06
AU2006334367B2 (en) 2012-11-08
ME01205B (me) 2013-03-20
CN101355937A (zh) 2009-01-28
HRP20110200T1 (hr) 2011-04-30
IL192602A (en) 2013-06-27
ES2362306T3 (es) 2011-07-01
MY146362A (en) 2012-08-15
US20150224090A1 (en) 2015-08-13
PT1971332E (pt) 2011-03-18
WO2007077162A1 (en) 2007-07-12
RS51703B (en) 2011-10-31
PL1971332T3 (pl) 2011-08-31
US20070155773A1 (en) 2007-07-05
KR20080083060A (ko) 2008-09-12

Similar Documents

Publication Publication Date Title
WO2009153665A3 (en) Inhibitors of the shiga toxins trafficking through the retrograde pathway
DK1765349T3 (da) Opioider til behandling af kronisk obstruktiv lungesygdom
MX346186B (es) Inhibidores de proteina cinasas.
EA201400591A1 (ru) Ингалятор
MX2010002732A (es) Inhibidores de f1f0-atpasa y metodos relacionados.
MX341212B (es) Inhibidor de bromodominio de benzodiazepina.
WO2007144327A3 (en) Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
WO2007048801A3 (en) Sexual desire enhancing medicaments comprising benzimidazolone derivatives
ATE524450T1 (de) 5-phenyl-isoxazol-3-carboxamid-derivate als trpv1-modulatoren
NO20084328L (no) Nye forbindelser
WO2012040636A3 (en) Compounds and methods for treating diseases mediated by protease activated receptors
TN2009000275A1 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
EA201171172A1 (ru) Применение в терапии производных хиназолиндиона
EA201290603A1 (ru) Способ лечения
EA201201397A1 (ru) Ингалятор, содержащий расслаиваемую блистерную упаковку
NO20082439L (no) Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
EA200900261A1 (ru) Применение эсцина
EA201201395A1 (ru) Кнопочное устройство мундштука ингалятора сухого порошка
NO20081480L (no) Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma
MX2008001506A (es) Uso de sales de triotropio en el tratamiento de asma severa persistente.
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
NZ597359A (en) Emergency interventions of active charcoal with dabigatran etexilate overdosing
WO2011056850A3 (en) Linaclotide for the treatment of chronic constipation
WO2008019388A3 (en) Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application